Dengue haemorrhagic fever (DHF) is a burden of disease in tropical countries, caused by any one of four-dengue virus (DENV) serotypes (DENV-1 to DENV-4). Although there have been many studies on patients with DHF, many things remain unclear, including the role of DENV serotypes and DENV concentration. The objective of this study was to determine the role of different serotypes and DENV concentration in the prognosis of dengue shock syndrome. This was a prospective cohort study, conducted to show information relating to patients' conditions, such as hematocrit, platelet, leukocytes, and DENV concentration and the differences between DENV serotypes. The study also expressed the relationship between two groups, DHF without shock and DHF with shock, in terms of immune status, different DENV serotypes, and DENV concentration. Two-hundred and thirty-four patients were serologically con irmed as having a DENV infection. On hospital admission day (fever within 72 hours), results showed that almost all patients had a secondary dengue infection (76.5 %). DENV-1 accounted for the highest number of cases (61.11%), and DENV-4 accounted for the lowest (0.43%). No statistically signi icant difference was found when comparing the two groups (DHF with shock and DHF without shock) or when comparing the groups of different DENV serotypes. The study concluded that different DENV serotypes or DENV concentration in the irst day of hospitalization (fever within 72 hours) cannot be used for prognostic of DSS.
INTRODUCTION
Dengue fever (DF) is a burden of disease and is a cause of mortality, especially in tropical regions such as Southeast Asia, Africa, and the Western Paci ic (Guzman et al., 2010) . Dengue virus (DENV)of the family Flaviviridae-is transmitted predominantly by Aedes aegypti mosquitoes and is caused by any one of four DENV serotypes (DENV-1 to DENV-4) (Simmons et al., 2012) .
About 50-80 million people each year are estimated to suffer from dengue infection, and at least 12,000-24,000 deaths occur, mainly among children under 15 years of age (World Health Organization, 2011; Simmons et al., 2012; Bhatt et al., 2013; Stanaway et al., 2013) . The years 2017-2018 witnessed a worldwide drop in the number of DF cases, but this was followed by a growth in cases in 2019, especially in Australia, Cambodia, China, Laos, Malaysia, the Philippines, Singapore, and Vietnam, countries that are endemic with DF (World Health Organization, 2019) . Approximately 500,000 cases every year lead to severe dengue in the form of dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) (Guzman et al., 2010) . Although DSS and vascular leakage is often mentioned in adult conditions, research in 2012 showed that these syndromes can generally be more severe in children . However, if no appropriate activities are managed, severe DF may result in rapid death, particularly in children (Huy et al., 2010; Sam et al., 2013) . The rate of mortality due to DSS ranges from <1% to >10, depending on the severity of DF and the experience of healthcare personnel (Wills et al., 2005; Bunnag and Kalayanarooj, 2011; Gupta et al., 2011) .
In Vietnam, after a presence of more than ive decades, DHF is becoming more and more complex and is developing faster. Epidemics are also developing, as well as there being an increase in the number of infected people and the proportion of mortality. DHF is an endemic disease and is an important challenge not only for Vietnam's public health activities but also for many other countries. Despite the burden of DHF and the increasing studies on DHF and DSS in Vietnam, there still remain some unclear things, such as the pathogenetic nature of the disease, the interaction between the immune system and DHF/DSS, the preventive vaccine, and the relationship of DENV concentration and DENV serotypes with DHF/DSS, etc. Therefore, this study was conducted with the objective of investigating more closely some of the above problems: the role of different serotypes and dengue virus concentration in the prognosis of dengue shock syndrome in children.
MATERIALS AND METHODS

Sample collection and selection
The prospective cohort study was conducted using data collected from Tien Giang Hospital. The study took into account children who all had the following characteristics: The sample size was de ined by the following formula from (Lwanga et al., 1991) .
Where α is the signi icant level of the test (the probability of type I error) in any hypothesis test. The coef icient Z (1−α /2) in this study was chosen as 1.96. P is the anticipated population proportion; in this study, a P value of 0.5 was considered safe in the sampling, and the margin error (d) was 5%. According to the formula, there needed to be at least 385 cases for DHF with shock and DHF without shock.
Patients who were not diagnosed with DHF did not complete the surveyor did not give consent were excluded from the study.
Laboratory methods
An amount of venous blood was collected from each child on hospital admission day and was put into EDTA-containing tubes for testing. DHF was conirmed by testing NS1 enzyme-linked immunosorbent assay (ELISA) and testing for dengue IgG/IgM by ELISA in each blood sample. The different dengue virus serotypes were determined using real-time reverse transcription-polymerase chain reaction (RT-PCR). Blood parameters continued to be monitored every day until the patients had clinical and hematological improvement.
The study also calculated the average hematocrit, platelet, leukocytes, and DENV concentration for each patient; this was also recorded.
Statistical analysis
For descriptive analyses, the study used number and percentage for categorical variables including gender, the severity of illness, immune status, day of fever, and distribution of DENV serotype. Continuous data were expressed as average and standard deviation (SD) and min-max. The study used a chisquared test to compare univariate categorical data and an independent sample t-test or one-way analysis of variance (ANOVA) to analyze the relationship among groups for continuous variables. All analyses were performed with the statistical software STATA 10.0.
Ethical considerations
Human research ethics was approved by the Ethics Committee of Tien Giang Hospital. The author commits that all information is collected for scienti ic purposes only. . DENV concentration was measured by day of fever and by immune status. DENV concentration was the highest at day 2 of fever with 7.74E + 08 (range [min-max]: 0-4.01E + 10). The higher DENV concentration was found in the secondary infection group, with the mean DENV concentration being 5.24E + 08. There was no statistically signi icant difference in terms of DENV concentration between the three groups of the day of fever or between the two groups of immune status; p-values were 0.2981 and 0.1268, respectively. Table 3 shows the differences of DENV serotype, immune status, and DENV concentration between the two groups, DHF with shock and DHF without shock. There was no association between the three subclinical characteristics and DENV concentration with the different DENV serotypes; all p-values in the test were more than 0.05.
RESULTS AND DISCUSSION
Characteristics of the study sample
Of the 234 children shown to be positive with dengue by the IgG/IgM (ELISA) test, the study results show that the proportion of DHF cases without shock (93.59%) was much higher than DHF cases with shock. This result is lower than Nguyen et al. (2004) , who studied 62 infants under 12 months who were diagnosed with DHF, including two groups: 69.3% of children with DHF without shock (level II) and 30.7% of children with DHF with shock (15 cases with level III and four cases with level IV).
Regarding immune status, the results illustrate that most of the cases were DENV secondary infections Tang et al.' s study, the proportion of primary infection was more than that of secondary infection (60.1 % and 39.9%, respectively). Children were mainly hospitalized when having fever on day 2 and day 3 with rates of 41.45% and 50.85%, respectively; very few patients were hospitalized for day 1 fever (7.69%).
Characteristics of different DENV serotypes during hospital admission day (fever within 72 hours)
The patient distribution by different DENV serotypes was as follows: the highest proportion was DENV-1 (61.11%), followed by DENV-3 (23.5%), DENV-2 (14.96%), and only one case was caused by DENV-4 (0.41%). Compared with the study of Tuan (2009) , the distribution of different DENV serotypes among patients was that DENV-1, DENV-2, DENV-3, and DENV-4 accounted for 62.8%, 27.4%, 8.8%, and 0.9%, respectively. It can clearly be seen from these two studies that DENV-1 is the predominant serotype causing DHF, and these results are also similar to those of Rathakrishnan et al. (2012) . This is also the conclusion in Huong et al. (2012) ; that is, that DENV-4 is still the serotype with the lowest proportion of DHF cases in southern Vietnam.
No statistically signi icant difference was found when comparing different DENV serotypes between the two groups, DHF without shock and DHF with shock (p > 0.05). In contrast, Tuan (2009) showed that the number of cases of DHF with shock caused by DENV-2 was seen much more, and patient condition was more severe than cases caused by DENV-1.
There is no statistically signi icant difference in terms of immune status between the two groups, DHF without shock and DHF with shock (p = 0.337).
The same result is seen in Bozza et al. (2008) (p = 0.3989), although the ability of those secondarily infected with severe DHF was greater than the mild DHF group at rates of 42% and 28%, respectively.
Regarding hematocrit, platelet, leukocytes, and DENV serotype concentration on hospital admission day, no statistically signi icant difference was found among the four different serotypes, DENV-1, DENV-2, DENV-3, and DENV-4.
Characteristics of DENV concentration on hospital admission day (fever within 72 hours)
The mean DENV concentration was 4.34E + 08 ± 2.84E + 09 (copies/ml), and no statistically significant difference was found among the four different serotypes (p= 0.8717). The mean DENV concentration on hospital admission day in the group DHF with shock was higher than in the group DHF without shock; however, this difference was not statistically signi icant (p = 0.084). Houghton-Trivino et al.
(2010) on 38 patients with DHF and DF also showed that there was no association between DENV concentration and the severity of DHF or DF.
DENV concentration means were seen to be different by fever day (day 1, day 2, or day 3); among them, mean DENV concentration was highest on day 2, but the difference among these fever days was not statistically signi icantly different (p = 0.2981).
Regarding immune status, mean DENV concentration in secondary infection cases was higher than in primary infection cases (5.24E + 08 ± 2.42E + 08 and 1.43E + 08 ± 5.49E + 07).
CONCLUSIONS
After analysis, the results show that there was no signi icant difference when comparing different DENV serotypes, immune status, and subclinical characteristics between the two groups, DHF with shock and DHF without shock. According to this research, different DENV serotypes and DENV concentration on hospital admission day (fever within 72 hours) still cannot be used for the prognosis of DSS.
